Company or institution

XENON PHARMACEUTICALS INC.

Save Like

124 applicationsfiled 2006 to 2025

Allowance rate

65%

−11 pts vs the USPTO range 55% to 73%

Rejections before allowance

1.2

−0.4 vs the USPTO

Months to first action

10.2 mo

−8.4 vs the USPTO

Needed an RCE

18%

−9 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07D Heterocyclic compounds72 apps

A61K Medical preparations31 apps

C07C 7 apps

A61P Therapeutic activity of compounds5 apps

C12N Microorganisms or enzymes4 apps

G01N Investigating or analysing materials4 apps

Art units

162637 apps

162521 apps

162416 apps

162210 apps

16287 apps

16216 apps

Examiners met

The examiners seen most, and how it went with each

Timothy R Rozof9 apps

75%

Shawquia Jackson6 apps

50%

Rebecca L Anderson6 apps

67%

Layla Soroush6 apps

50%

Daniel R Carcanague5 apps

80%

Heidi L Reese4 apps

100%

Golam M Shameem4 apps

100%

Celia C Chang3 apps

100%

Bars show the share of decided applications that were allowed.

Unlock the examiners this company meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents on their applications

Seed IP Law Group LLP/Xenon Pharmaceuticals35 apps

63%

VIKSNINS HARRIS PADYS MALEN LLP31 apps

68%

WOLF GREENFIELD & SACKS, P.C.29 apps

80%

Knobbe, Martens, Olson & Bear, LLP8 apps

88%

COOLEY LLP6 apps

25%

FISH & RICHARDSON P.C. (Neurocrine Biosciences)6 apps

50%

Alan J. Grant, Esq.2 apps

50%

CARELLA, BYRNE, CECCHI, OLSTEIN, BRODY & AGNELLO2 apps

50%

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19617543	AZETUKALNER FOR USE IN THE TREATMENT OF DEPRESSION, ANHEDONIA OR A SEIZURE DISORDER…	2026-08-21	Pending	0	0	n/a
19582736	SUBSTITUTED ARYL SULFONAMIDES FOR USE AS SODIUM CHANNEL INHIBITORS	2026-04-28	Pending	0	0	n/a
19520640	DEUTERIUM AND ARYL AMINE COMPOUNDS AND USES THEREOF	2026-03-18	Pending	0	0	n/a
15584343	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15800573	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15966593	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15318685	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15107698	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15823199	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15993255	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 124 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in